Kisspeptin-10 vs PT-141 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Kisspeptin-10 is the minimal biologically active fragment of kisspeptin - the peptide product of the KISS1 gene that acts as the master regulator of reproductive axis activation. It acts exclusively on the kisspeptin receptor (KISS1R / GPR54), which is expressed on hypothalamic G...
Calculate Kisspeptin-10 dose →PT-141 (Bremelanotide) is an FDA-approved cyclic heptapeptide that activates melanocortin receptors MC3R and MC4R in the central nervous system to drive sexual arousal. Unlike PDE5 inhibitors, it acts centrally on desire rather than peripheral vasodilation. FDA-approved as Vylees...
Calculate PT-141 dose →| Parameter | Kisspeptin-10 | PT-141 |
|---|---|---|
| Category | Reproductive & Hormonal | Sexual Health & Melanocortin |
| Research | Extensively Studied | FDA Approved |
| Half-Life | ~28–30 min | ~2.7 hours |
| Typical Dose | 1–10 µg/kg (clinical); 0.5–2 mg (research) | 1.75 mg (FDA); 1–2 mg research |
| Frequency | Pulsatile (every 90 min) or bolus as needed | As needed (max 1× per 24h) |
| Route | Subcutaneous / Intravenous (clinical) | Subcutaneous |
| FDA Status | Not Approved | Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.